T1	Participants 142 237	polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis
T2	Participants 555 566	62 patients
T3	Participants 348 413	severe polyarteritis nodosa (PAN) and Churg-Strauss syndrome (CSS
